首页> 外国专利> CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND THEIR PHARMACEUTICAL USE

CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND THEIR PHARMACEUTICAL USE

机译:基于环丙基的吡咯烷二肽肽酶IV的抑制剂及其药物用途

摘要

Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula (I) where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1); n is 0 or 1; X is H; and wherein R 1 , R 2 , R 3 and R 4 are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity and/or other therapeutic agent.
机译:提供具有式(I)的二肽基肽酶IV(DP 4)抑制化合物,其中x为0或1,且y为0或1(条件是当y = 0时x = 1,而y = 1时x = 0); n为0或1; X是H;其中R 1,R 2,R 3和R 4如本文所述。还提供了使用此类DP 4抑制剂或此类DP 4抑制剂与一种或多种其他抗糖尿病药(如二甲双胍)的组合治疗糖尿病和相关疾病(尤其是II型糖尿病)和本文所述的其他疾病的方法,格列本脲,曲格列酮,吡格列酮,罗格列酮和/或胰岛素和/或降血脂药和/或抗肥胖药和/或其他治疗剂中的一种或多种。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号